Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Patient activation with respect to advanced heart failure therapy in patients over age 65 years
Sandra A Carey1, Kristen M Tecson2, Kyle Bass3
1Center for Advanced Heart and Lung Disease, Baylor University Medical Center, 3410 Worth Street, Suite 250, Dallas, TX 75246, USA; Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, 3410 Worth Street, Suite 560, Dallas, TX 75246, USA.
Insights
Patient activation, or self-management ability, is high in elderly patients considered for advanced heart failure (HF) therapies. Age should not be a barrier to receiving advanced HF treatment.
Area of Science:
- Cardiology
- Geriatrics
- Health Psychology
Background:
- Determining candidacy for advanced heart failure (HF) therapies in elderly patients presents clinical and ethical challenges.
- Patient 'activation,' defined as engagement and self-management capacity, is a key selection factor.
Purpose of the Study:
- To examine the influence of age, patient activation, and psychological factors (depression/anxiety) on selection for advanced HF therapy.
- To assess the impact of these factors on 6-month survival rates in patients considered for therapy.
Main Methods:
- Consecutive patients referred for advanced HF therapy completed validated measures of patient activation and anxiety/depression.
- Data were analyzed comparing participants aged ≥65 years versus <65 years, stratified by therapy approval.
Main Results:
- Of 168 referred patients, 109 were approved for therapy.
- Patient activation levels were high (88%) and did not differ significantly between age groups, both among approved and non-approved candidates.
- Activation correlated with anxiety in older, approved participants, but not with depression.
Conclusions:
- Concerns about reduced self-management capabilities in elderly patients considered for advanced HF therapy may be unfounded.
- Chronological age alone should not preclude patients from receiving advanced heart failure therapies.
Background:
Clinical and ethical issues persist in determining candidacy for advanced heart failure (HF) therapies in elderly patients. Selection takes many factors into account, including "activation" (engagement and ability to self-manage).
Objective:
To investigate effects of age, activation, and depression/anxiety on selection and 6-month survival of participants considered for therapy.
Methods:
Consecutive people referred for advanced HF therapy completed the Patient Activation Measure and Hospital Anxiety and Depression Scale. We analyzed data from participants by age (≥65 vs. <65 years), stratified by approval for therapy.
Results:
Among 168 referred, 109 were approved, with no difference in activation between age groups (88% highly activated). Similarly, activation was not associated with age among those not approved. Activation was related to anxiety in older, approved participants, but not to depression.
Conclusions:
Concerns regarding reduced self-management in the elderly may not be valid. Age alone should not disqualify a candidate for advanced HF therapy.
More Related Videos
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion